EMD-19181
Beta-galactosidase (LacZ) purified from E. coli.
EMD-19181
Single-particle2.06 Å
Deposition: 18/12/2023Map released: 01/01/2025
Last modified: 01/04/2026
Sample Organism:
Escherichia coli
Sample: beta-galactosidase
Fitted models: 8ri6
Deposition Authors: Hardenbrook NJ, Sheng Y
,
Zhang P
Sample: beta-galactosidase
Fitted models: 8ri6
Deposition Authors: Hardenbrook NJ, Sheng Y
,
Zhang P
Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiology.
Sanguankiattichai N ,
Chandrasekar B,
Sheng Y ,
Hardenbrook N ,
Tabak WWA ,
Drapal M ,
Kaschani F ,
Grunwald-Gruber C ,
Krahn D ,
Buscaill P ,
Yamamoto S,
Kato A ,
Nash R ,
Fleet G,
Strasser R ,
Fraser PD,
Kaiser M ,
Zhang P ,
Preston GM ,
van der Hoorn RAL
(2025) Science , 388 , 297 - 303
,
Chandrasekar B,
Sheng Y ,
Hardenbrook N ,
Tabak WWA ,
Drapal M ,
Kaschani F ,
Grunwald-Gruber C ,
Krahn D ,
Buscaill P ,
Yamamoto S,
Kato A ,
Nash R ,
Fleet G,
Strasser R ,
Fraser PD,
Kaiser M ,
Zhang P ,
Preston GM ,
van der Hoorn RAL
(2025) Science , 388 , 297 - 303
Grant Support:
- Biotechnology and Biological Sciences Research Council (BBSRC): BB/T015128/1 (United Kingdom)
- Biotechnology and Biological Sciences Research Council (BBSRC): BB/R017913/1 (United Kingdom)
- European Research Council (ERC): 101021133 (European Union)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): U54 AI170791-7522 (United States)
- Wellcome Trust: 206422/Z/17/Z (United Kingdom)